Alcon to Launch New Cataract Surgery Device
Alcon introduced CE-marked Clareon intraocular lens with an automated delivery system at the European Society of Cataract and Refractive Surgeons Congress in October 2017.
Alcon, global leader in eye care, develops, and manufactures innovative medicines and devices to serve eye care needs. The company recently presented data for the Clareon device as well as studies of other devices. According to the Alcon, Clareon intraocular lens (IOL) is made of advanced optic material, which is delivered through an automated, disposable, and preloaded system. It has been described as a next-generation polymer material that maintains the benefits of Alcon’s AcrySof platform.
“We are proud to deliver on our commitment to bring innovations to the surgical community, and Clareon is one of the biggest breakthroughs in the IOL space,” said Alcon CEO Mike Ball. “This is a great year for Alcon as we celebrate many important milestones—from fulfilling our mission to help people see better by enhancing and transforming the way surgeons treat cataracts through innovations like Clareon, to marking the 100 millionth implant of our flagship AcrySof lenses.”
According to the National Eye Institute, conventionally early cataracts are treated with new eyeglasses, magnifying lenses, and antiglare sunglasses. Cataract surgery involves removal of cataract and implantation of an IOL, which is required when the cataract interferes with a patient’s everyday activity or if the cataract doesn’t allow treatment of a different eye condition.
Novartis is expecting FDA approval for the Clareon, PanOptix trifocal, and trifocal toric lenses by 2019. According to Cataract Surgery Devices Market report published by Coherent Market Insights, although cataract does not interfere the eyesight in the early stages, it interferes with vision and may lead to blindness over the course of time. Cataract surgery is the most commonly performed ophthalmic procedure and it holds a great potential for the growth of cataract surgery devices market. Introduction of new devices in market could offer potential for effective treatment of Cataract.
You may be interested
Oncology Biosimilars Market – Trends Research & Projections for 2017-2025Albert R - February 21, 2018
Biosimilar is a biological product that resembles a reference product and is not difference from the already approved reference product. These are relatively cheaper than branded or…
Tubeless Insulin Pump Market – Global Industry Insights, Trends, Opportunity Analysis 2017-2025Albert R - February 20, 2018
Tubeless insulin pump is a portable pump, which is effective in controlling blood glucose level. Advancements in technologies of insulin pumps, which reduce the need for daily…
Cervical Pillow Market – Global Industry Insights, Outlook, Opportunity Analysis, 2017-2025Albert R - February 20, 2018
Cervical pillow is used to support the natural position of the head and neck while sleeping with different positions such as supine lying positions or side sleeping…